: Four-dimensional (4D) flow cardiovascular magnetic resonance imaging (MRI) is an emerging technique used for intra-cardiac blood flow assessment. The role of 4D flow cardiovascular MRI in the assessment of trans-valvular flow in patients with atrial fibrillation (AF) has not previously been assessed. The purpose of this study was to assess the feasibility, image quality, and internal validity of 4D flow cardiovascular MRI in the quantification of trans-valvular flow in patients with AF. : Patients with AF and healthy controls in sinus rhythm underwent cardiovascular MRI, including 4D flow studies. Quality assurance checks were done on the raw data and streamlines. Consistency was investigated by trans-valvular flow assessment between the mitral valve (MV) and the aortic valve (AV). : Eight patients with AF (88% male, mean age 62±13 years, mean heart rate (HR) 83±16 beats per minute (bpm)) were included and compared with ten healthy controls (70% male, mean age 41±20 years, mean HR 68.5±9 bpm). All scans were of either good quality with minimal blurring artefacts, or excellent quality with no artefacts. No significant bias was observed between the AV and MV stroke volumes in either healthy controls (-4.8, 95% CI -15.64 to 6.04; P=0.34) or in patients with AF (1.64, 95% CI -4.7 to 7.94; P=0.56). A significant correlation was demonstrated between MV and AV stroke volumes in both healthy controls (r=0.87, 95% CI 0.52 to 0.97; P=0.001) and in AF patients (r=0.82, 95% CI 0.26 to 0.97; P=0.01). : In patients with AF, 4D flow cardiovascular MRI is feasible with good image quality, allowing for quantification of trans-valvular flow.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150120PMC
http://dx.doi.org/10.12688/wellcomeopenres.16655.2DOI Listing

Publication Analysis

Top Keywords

trans-valvular flow
20
flow cardiovascular
20
cardiovascular mri
16
healthy controls
16
flow
12
four-dimensional flow
8
cardiovascular magnetic
8
magnetic resonance
8
resonance imaging
8
patients
8

Similar Publications

Introduction: The Impella 5.5 device is a surgically inserted, trans-valvular, microaxial flow device capable of providing 5.5 L/min of continuous, antegrade flow from the left ventricle (LV) to the aorta.

View Article and Find Full Text PDF
Article Synopsis
  • - In a study involving pig models, researchers examined the inflammatory responses to two treatment methods for cardiogenic shock: veno-arterial extracorporeal membrane oxygenation (V-A ECMO) and a combination of V-A ECMO with trans valvular micro axial flow pumps (ECMELLA).
  • - The results showed that both treatment groups experienced increased levels of inflammatory biomarkers such as interleukin 6 (IL-6), IL-8, and serum amyloid A (SAA), with notably higher IL-6 and SAA levels in the ECMELLA group at certain time points.
  • - Despite these heightened inflammatory responses, no significant differences were found between the two groups in terms of crucial clinical
View Article and Find Full Text PDF

Background: Automated 4D flow MRI valvular flow quantification without time-consuming manual segmentation might improve workflow.

Purpose: Compare automated valve segmentation (AS) to manual (MS), and manually corrected automated segmentation (AMS), in corrected atrioventricular septum defect (c-AVSD) patients and healthy volunteers, for assessing net forward volume (NFV) and regurgitation fraction (RF).

Study Type: Retrospective.

View Article and Find Full Text PDF

Danish-German cardiogenic shock trial-DanGer shock: Trial design update.

Am Heart J

January 2023

Department of Clinical Research, University of Southern Denmark, Odense, Denmark; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.

Background: The main objective of the Danish German Cardiogenic Shock trial (DanGer Shock ClinicalTrials.gov Identifier: NCT01633502) is to assess the efficacy of the trans valvular axial flow device Impella CP in treating patients with AMICS shock due to STEMI undergoing emergency percutaneous coronary intervention.

Methods: This statistical analysis plan represents an overview of the statistical methods which will be used for analyzing the DanGer Shock trial.

View Article and Find Full Text PDF

Prolonged mechanical circulatory support (MCS) for severe left ventricular dysfunction in cardiogenic shock as a bridge to heart transplantation (HTx) generally requires a surgical procedure. Typically, a surgically implanted temporary extracorporeal left ventricular assist device (LVAD) is chosen because of superior flow and durability compared with a percutaneously delivered endovascular LVAD (pVAD). However, compared with its predecessors, the Impella 5.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!